Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (378405)
- Canadian Institutes of Health Research (93326)
- Canadian Institutes of Health Research (NCT00920348)
- AstraZeneca Canada
- Reseau canadien de recherche respiratoire
- Santé
- Novartis
- McGill University
- McGill University Health Centre
- Boehringer Ingelheim Canada
This publication has 31 references indexed in Scilit:
- Airflow Obstruction, Lung Function, and Risk of Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) StudyEuropean Journal of Heart Failure, 2012
- Co-morbidity in Mild-to-Moderate COPD: Comparison to Normal and Restrictive Lung FunctionCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2011
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)European Heart Journal, 2011
- Cardiovascular events in patients with COPD: TORCH Study resultsThorax, 2010
- Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohortThorax, 2008
- Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEuropean Respiratory Journal, 2008
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failureJournal of Clinical Epidemiology, 2004
- Validity of a Self-reported History of Doctor-diagnosed AnginaJournal of Clinical Epidemiology, 1999
- Importance of events per independent variable in proportional hazards regression analysis II. Accuracy and precision of regression estimatesJournal of Clinical Epidemiology, 1995